R
$70–107.5K / year · Remote · United States
Resilience provides development, scale-up and technology-transfer services for biopharmaceuticals, including cell and gene therapies, viral vectors, vaccines and proteins.
Resilience is a biomanufacturing company providing end-to-end development, scale-up and technology-transfer services for complex medicines. Its work includes cell and gene therapies, viral vectors, vaccines and proteins.
Founded in 2020, the company has facilities in Blue Ash, Ohio, where it is headquartered, as well as Cincinnati, Philadelphia and Toronto. It serves pharmaceutical and biotechnology companies, universities and government programmes.
Resilience launched with more than $800 million in capital. It has also secured $825 million in long-term financing and $410 million from the U.S. Department of Defense.